Chronic Kidney Disease-Mineral Bone Disorders (CKD MBD) is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerular filtration rate (GFR) due to renal impairment. This report provides an assessment of the pipeline, clinical, and commercial landscape of CKD MBD. Overall, Grand Research Store expects minimal changes to overall disease treatment, with exceptions being the launch of the novel NHE3 and novel CASR in the US and Japan markets respectively. Download free Sample Report @ http://bit.ly/2GZ3qQi Scope Pipeline Assessment: regional breakdown, promising late stage products, early stage pipeline by molecule type Clinical Trials Assessment: trial breakdown by phase, leading industry and non industry sponsors, enrollment analytics Commercial Assessment: leading marketed products, current and future players Competitive Land...